INSMED Inc (INSM) Income statement

Market cap

$29.4B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Revenue	4	-	12	-	-	-	-	10	136	164	188	245	305	364	606
Revenue growth (%)	-	-	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-	-	2	24	40	44	55	66	86	123
Gross profit	-	-	-	-	-	-	-	-	112	-	-	-	-	-	-
Gross margin (%)	-	-	-	-	-	-	-	-		-	-	-	-	-	-
Research & development	28	30	44	56	74	123	110	145	132	181	273	398	571	598	771
Selling, general & administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	461	701
Operating margin (%)		-		-	-	-	-
Operating expenses	66	42	67	87	117	173	189	317	348	430	564	703	1,015	1,242	1,853
Operating income	-62	-42	-55	-87	-117	-173	-189	-307	-235	-265	-375	-457	-710	-878	-1,247
Income before tax	-60	-41	-57	-90	-120	-176	-193	-324	-254	-293	-436	-480	-747	-910	-1,272
Pretax margin (%)	-1,350.8	-	-498.2	-	-	-	-	-3,295.1	-185.8	-178	-231.6	-195.7	-244.8	-250.2	-209.7
Provision for income taxes	-	-	-1	-10	-2	0	-0	0	1	1	-2	1	3	4	5
Effective tax rate (%)	-	-
Net income	-60	-41	-56	-79	-118	-176	-193	-324	-254	-294	-435	-482	-750	-914	-1,277
Net income margin (%)		-		-	-	-	-
Earnings per share	-2.95	-	-	-	-	-	-	-	-	-	-3.88	-3.91	-5.34	-5.57	-6.42
Diluted EPS	-2.95	-	-	-	-	-	-	-	-	-	-3.88	-3.91	-5.34	-5.57	-6.42
EBITDA								-	-	-	-	-	-	-	-
EBITDA margin (%)		-		-	-	-	-	-	-	-	-	-	-	-	-